CALR and ocular melanoma: OM may or may not associated with autoantibodies including anti‐U1RNP, anti‐Ku, anti‐PM‐Scl, anti‐RuvBL, anti‐RuvBL2, anti‐Ro/SS‐A, and anti‐La/SS‐B.